Join TransCode Therapeutics' Live Investor Webinar: Advancing a Multi-Platform Oncology Pipeline Targeting Metastatic Cancer
Go back to Join TransCode Therapeutics' Live Investor Webinar: Advancing a Multi-Platform Oncology Pipeline Targeting Metastatic Cancer| (NASDAQ: RNAZ) | Delayed: 1.74 +0.08 (4.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.66 | 52 Week High | $ | |||
| Open | $1.62 | 52 Week Low | $ | |||
| Day High | $1.80 | P/E | N/A | |||
| Day Low | $1.62 | EPS | $ | |||
| Volume | 20,641 | |||||



